FDA Inspection 1114708 — American Red Cross Blood Services - Southwest Region
The FDA completed an inspection of American Red Cross Blood Services - Southwest Region on December 17, 2019 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 17, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)